These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1095963)

  • 1. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
    Cantoni L; Maggi G; Mononi G; Preti G
    Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study].
    Ideo G
    Minerva Med; 1975 May; 66(33):1571-80. PubMed ID: 1095962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind polycentric study of the action of S-adenosylmethionine in hepatic cirrhosis].
    Labo G; Miglio F; D'Ambro A; Bellobuono A; Ideo G; Dioguardi N; Bernardi M; Corazza GR; Gasbarrini G; Avogaro P; Pasquino M
    Minerva Med; 1975 May; 66(33):1590-4. PubMed ID: 1095964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind studies of the therapeutic action of S-Adenosylmethionine (SAMe) in oral administration, in liver cirrhosis and other chronic hepatitides].
    Miglio F; Stefanini GF; Corazza GR; D'Ambro A; Gasbarrini G
    Minerva Med; 1975 May; 66(33):1595-9. PubMed ID: 1095965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 7. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 8. [S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
    Frezza M; Pozzato G; Valente G; Gilotta S; Milani S; Nicolini R
    Minerva Med; 1977 Apr; 68(17):1105-14. PubMed ID: 857203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies].
    Dioguardi N; Ideo G; De Franchis R; Ronchi G
    Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].
    Garassini G; Sarnari V
    Minerva Gastroenterol; 1974; 20(1):19-26. PubMed ID: 4827982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
    Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
    Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience in heptral treatment of diffuse liver diseases].
    Gorbakov VV; Galik VP; Kirillov SM
    Ter Arkh; 1998; 70(10):82-6. PubMed ID: 9864813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of heptral in chronic liver diseases].
    Vostrikov GP; Toporkov AS
    Eksp Klin Gastroenterol; 2002; (6):52-4, 113. PubMed ID: 12685015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis.
    Glorioso S; Todesco S; Mazzi A; Marcolongo R; Giordano M; Colombo B; Cherie-Ligniere G; Mattara L; Leardini G; Passeri M
    Int J Clin Pharmacol Res; 1985; 5(1):39-49. PubMed ID: 3888864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.